Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3Terminated 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Pain, Postoperative 1Neoplasms 1Hereditary leiomyomatosis and renal cell cancer 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1Breast Diseases 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 454Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Botulinum Toxins, Type A × Clear all
NCT02965976 2023-02-16

Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer

Roswell Park Cancer Institute

Phase 2 Completed
33 enrolled 17 charts
Gastrointestinal

Esophageal Neoplasms

NCT01591746 2019-10-10

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

Mayo Clinic

Phase 3 Completed
131 enrolled 11 charts
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Pain, Postoperative

NCT00971620 2017-04-07

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
18 enrolled 22 charts
Genitourinary

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡